arrow
M

Megan Ludwig

University of Minnesota
H指数:14
被引数:536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients

血浆外泌体蛋白质组学为177Lu-PSMA-617治疗转移性前列腺癌患者的结局提出了候选生物标志物

2026-04-200
OAAI
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

作者更正:CREB5 促进致瘤性并上调可成药性细胞表面模态在基底样乳腺癌中

2025-11-200
OAAI
CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma

CRISPR 筛选确定 PIK3C2A 为头颈鳞状细胞癌中 EGFR 抑制剂耐药的新型介导因子

2025-09-010
OAAI
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

CREB5促进基底样乳腺癌的致瘤性,并上调可靶向的细胞表面模式识别分子。

2025-08-060
OAAI
PSMA-based detection and global proteome-based analysis of circulating tumor cells in castration resistant prostate cancer patients

基于PSMA的去势抵抗性前列腺癌患者循环肿瘤细胞检测和整体蛋白质组分析

2024-03-220
PRE
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

CREB5重新编程FOXA1核相互作用以促进对雄激素受体靶向疗法的抗性

2022-05-1213
OAAI